English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/16129
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Binding profile of the endogenous novel heptapeptide Met-enkephalin-Gly-tyr in zebrafish and rat brain

AuthorsGonzález-Nuñez, V.; Arsequell, Gemma; Szemenyei, E.; Toth, G.; Valencia Parera, Gregorio; Rodríguez, R. E.
Zebrafish brain
Rat brain
Endogenous heptapeptides
Issue Date18-May-2005
PublisherAmerican Society for Pharmacology and Experimental Therapeutics
CitationJournal of Pharmacology and Experimental Therapeutics 314(2): 862-867 (2005)
AbstractZebrafish is considered a model organism, not only for the study of the biological functions of vertebrates but also as a tool to analyze the effects of some drugs or toxic agents. Five opioid precursor genes homologous to the mammalian opioid propeptide genes have recently been identified; one of these, the zebrafish proenkephalin, codes a novel heptapeptide, the Met-enkephalin-Gly-Tyr (MEGY). To analyze the pharmacological properties of this novel ligand, we have labeled it with tritium ([3H]MEGY). In addition, we have also synthesized two analogs: (D-Ala2)-MEGY (Y-D-Ala-GFMGY) and (D-Ala2, Val5)-MEGY (Y-D-Ala-GFVGY). The binding profile of these three agents has been studied in zebrafish and rat brain membranes. [3H]MEGY presents one binding site in zebrafish, as well as in rat brain membranes, although it shows a slight higher affinity in zebrafish brain. The observed saturable binding is displaced by naloxone, thus confirming the opioid nature of the binding sites. Competition binding assays indicate that the methionine residue is essential for high-affinity binding of MEGY and probably of other peptidic agonists in zebrafish, whereas the change of a Gly for a D-Ala does not dramatically affect the ligand affinity. Our results show that the percentage of [3H]MEGY displaced by all the ligands studied is higher than 100%, thus inferring that naloxone (used to determine nonspecific binding) does not bind to all the sites labeled by [3H]MEGY. Therefore, we can deduct that some of the MEGY binding sites should not be considered classical opioid sites.
Description6 pages, 3 figures, 2 tables.-- PMID: 15901806 [PubMed].-- Printed version published Aug 2005.
Publisher version (URL)http://dx.doi.org/10.1124/jpet.105.084558
Appears in Collections:(IQAC) Artículos
Files in This Item:
There are no files associated with this item.
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.